Results 21 to 30 of about 23,057 (164)

Biochemical and Biophysical Characterization of Recombinant Human 3-Phosphoglycerate Dehydrogenase. [PDF]

open access: yesInt J Mol Sci, 2021
The human enzyme D-3-phosphoglycerate dehydrogenase (hPHGDH) catalyzes the reversible dehydrogenation of 3-phosphoglycerate (3PG) into 3-phosphohydroxypyruvate (PHP) using the NAD+/NADH redox cofactor, the first step in the phosphorylated pathway producing L-serine.
Murtas G   +4 more
europepmc   +5 more sources

The Global mRNA Expression Profiles of Inhibiting PHGDH Induced Cisplatin Resistance in Gastric Cancer [PDF]

open access: yesCell Journal, 2022
Objective: Drug resistance is the main hindrance to improve the prognosis of patients with gastric cancer. Aminoacid metabolic reprograming is essential to satisfy the different requirements of cancer cells during drug resistance,of which serine ...
Kailing Pan, Xiaoya Zhao, Wenxia Xu
doaj   +1 more source

On the quaternary structure of human D-3-phosphoglycerate dehydrogenase. [PDF]

open access: yesProtein Sci
AbstractD‐3‐phosphoglycerate dehydrogenase (PHGDH) catalyzes the NAD+‐dependent conversion of D‐3‐phospho‐glycerate to 3‐phosphohydroxypyruvate, the first step in the phosphorylated pathway for L‐serine (L‐Ser) biosynthesis. L‐Ser plays different relevant metabolic roles in eukaryotic cells: alterations in L‐Ser metabolism have been linked to serious ...
Riva D   +3 more
europepmc   +4 more sources

Inhibition of Phosphoglycerate Dehydrogenase Attenuates Bleomycin-induced Pulmonary Fibrosis [PDF]

open access: yesAmerican Journal of Respiratory Cell and Molecular Biology, 2018
Robert B Hamanaka   +2 more
exaly   +2 more sources

Renal UTX-PHGDH-serine axis regulates metabolic disorders in the kidney and liver

open access: yesNature Communications, 2022
Chen et al. report on a renal UTX-phosphoglycerate dehydrogenase axis that regulates serine secretion to affect lipid metabolism in the kidney and liver upon over-nutrition, suggesting potential treatment targets for obesity-related diseases.
Hong Chen   +15 more
doaj   +1 more source

PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma

open access: yesNature Communications, 2023
The role of protein arginine methylation in serine metabolism of cancer cells in hepatocellular carcinoma (HCC) remains to be explored. Here, the authors show that phosphoglycerate dehydrogenase (PHGDH) is activated by PRMT1-mediated R236 methylation ...
Kui Wang   +13 more
doaj   +1 more source

Lactate Limits T Cell Proliferation via the NAD(H) Redox State

open access: yesCell Reports, 2020
Summary: Immune cell function is influenced by metabolic conditions. Low-glucose, high-lactate environments, such as the placenta, gastrointestinal tract, and the tumor microenvironment, are immunosuppressive, especially for glycolysis-dependent effector
William J. Quinn, III   +22 more
doaj   +1 more source

Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2021
The small-molecule inhibitor of phosphoglycerate dehydrogenase, NCT-503, reduces incorporation of glucose-derived carbons into serine in vitro.
Birte Arlt   +6 more
doaj   +1 more source

Targeting one-carbon metabolism requires mTOR inhibition: a new therapeutic approach in osteosarcoma

open access: yesMolecular & Cellular Oncology, 2021
The rate-limiting enzyme of serine biosynthesis, 3-phosphoglycerate dehydrogenase (PHGDH), contributes to rapid growth and proliferation when it is overexpressed in cancer.
Richa Rathore, Brian Van Tine
doaj   +1 more source

3-phosphoglycerate dehydrogenase gene polymorphism amongst patients with thyroid gland cancer [PDF]

open access: yesMedicinski Podmladak, 2016
Introduction: Thyroid gland cancer is a rare malignancy in the male population, accounting for up to 2% of all cancers, but it is the most common cancer of the endocrine system, making up to 95% of all estimated new endocrine cancer cases each year ...
Pjevalica Jelena   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy